The research team Epilogy, Epidemiology and Evaluation of Therapeutics in Dermatology and Immune-Mediated Inflammatory Diseases publishes regularly in high-impact international journals in the fields of dermatology, epidemiology, therapeutic evaluation, and immune-mediated inflammatory diseases.

The team’s work is featured in well-recognized journals such as the Journal of the American Academy of Dermatology (JAAD), JAMA Dermatology, and Annals of the Rheumatic Diseases, reflecting the scientific quality, clinical relevance, and methodological rigor of its research.

These publications highlight the team’s expertise in real-world data analysis, treatment safety and effectiveness, causal inference, and evidence-based medicine, and contribute to advancing knowledge in dermatological and rheumatological diseases while supporting better clinical practice and public health decision-making.